Skip to content
healthcare.dev

Ticagrelor

NDC 60505-4452, Ticagrelor, tablet, from Apotex Corp..

Product NDC
60505-4452
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208584
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4452 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICAGRELOR90 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
60505-4452-66050544520660 TABLET in 1 BOTTLE (60505-4452-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2c59ea45-6113-6e9e-70b5-3b8c8b3d89b6
  • NADAC price for package 60505445206

    GET /v1/drugs/nadac/60505445206

Use it

Look up 60505-4452 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4452 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-4452. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.